Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Swertiamaroside
1. 17388-39-5
2. Swertiamarine
3. Swertiamaroside
4. Mls002473253
5. Chebi:9370
6. Chembl456138
7. (3s,4r,4ar)-4-ethenyl-4a-hydroxy-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4,5,6-tetrahydropyrano[3,4-c]pyran-8-one
8. 4038595t7y
9. Ac1l9ctk
10. Unii-4038595t7y
11. 1h,3h-pyrano(3,4-c)pyran-1-one, 5-ethenyl-6-(beta-d-glucopyranosyloxy)-4,4a,5,6-tetrahydro-4a-hydroxy-, (4ar,5r,6s)-
12. 1h,3h-pyrano[3,4-c]pyran-1-one, 5-ethenyl-6-(beta-d-glucopyranosyloxy)-4,4a,5,6-tetrahydro-4a-hydroxy-, (4ar,5r,6s)-
13. Mfcd07783984
14. Swertamarin
15. Brn 0055278
16. Swertiamarin [mi]
17. Surecn422560
18. 4-19-00-02723 (beilstein Handbook Reference)
19. Schembl422560
20. Swertiamarin [who-dd]
21. Megxp0_000871
22. Acon1_000546
23. Swertiamarin, Analytical Standard
24. Dtxsid50169676
25. Hms2205k13
26. Hy-n0807
27. Zinc4098354
28. S3927
29. Akos015965365
30. Ac-8039
31. Ccg-268346
32. Swertiamarin, >=95% (lc/ms-elsd)
33. Ncgc00168975-01
34. Ncgc00168975-03
35. (3s,4r,4ar)-4a-hydroxy-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4-vinyl-3,4,5,6-tetrahydropyrano[3,4-c]pyran-8-one
36. Bs-16249
37. Smr001397340
38. Cs-0009812
39. N1348
40. C09800
41. 388s395
42. A811580
43. Q-100208
44. Brd-k15387485-001-01-1
45. Q27108363
46. F0001-0632
47. (3s,4r,4ar)-4a-hydroxy-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4-vinyl-3,4,5,6-tetrahydropyrano[3,4-c]pyran-8-one;swertiamarine
48. (4ar,5r,6s)-4a-hydroxy-6-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-5-vinyl-4,4a,5,6-tetrahydropyrano[3,4-c]pyran-1(3h)-one
49. 1h,3h-pyrano(3,4-c)pyran-1-one, 5-ethenyl-6-(.beta.-d-glucopyranosyloxy)-4,4a,5,6-tetrahydro-4a-hydroxy-, (4ar,5r,6s)-
50. 1h,3h-pyrano(3,4-c)pyran-1-one, 5-ethenyl-6-(beta-d-glucopyranosyloxy)-4,4a,5,6-tetrahydro-4a-hydroxy-, (4ar-(4aalpha,5beta,6alpha))-
| Molecular Weight | 374.34 g/mol |
|---|---|
| Molecular Formula | C16H22O10 |
| XLogP3 | -2 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 4 |
| Exact Mass | 374.12129689 g/mol |
| Monoisotopic Mass | 374.12129689 g/mol |
| Topological Polar Surface Area | 155 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 592 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
35
PharmaCompass offers a list of Swertiamarin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Swertiamarin manufacturer or Swertiamarin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Swertiamarin manufacturer or Swertiamarin supplier.
PharmaCompass also assists you with knowing the Swertiamarin API Price utilized in the formulation of products. Swertiamarin API Price is not always fixed or binding as the Swertiamarin Price is obtained through a variety of data sources. The Swertiamarin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Swertiamarin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Swertiamarin, including repackagers and relabelers. The FDA regulates Swertiamarin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Swertiamarin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Swertiamarin supplier is an individual or a company that provides Swertiamarin active pharmaceutical ingredient (API) or Swertiamarin finished formulations upon request. The Swertiamarin suppliers may include Swertiamarin API manufacturers, exporters, distributors and traders.
Swertiamarin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Swertiamarin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Swertiamarin GMP manufacturer or Swertiamarin GMP API supplier for your needs.
A Swertiamarin CoA (Certificate of Analysis) is a formal document that attests to Swertiamarin's compliance with Swertiamarin specifications and serves as a tool for batch-level quality control.
Swertiamarin CoA mostly includes findings from lab analyses of a specific batch. For each Swertiamarin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Swertiamarin may be tested according to a variety of international standards, such as European Pharmacopoeia (Swertiamarin EP), Swertiamarin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Swertiamarin USP).
